Eiger completes follow-on

Eiger BioPharmaceuticals Inc. (NASDAQ:EIGR), Palo Alto, Calif. Business: Infectious, Endocrine/Metabolic, Cardiovascular Date completed: 2016-08-18 Type: Follow-on Raised: $20 million Shares: 1.3 mill...